Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[On-the-street DOTS for a homeless tuberculosis patient--case report of a patient who had difficulties with TB treatment adherence].

Kekkaku : [Tuberculosis]·2013

Same author

[The background of drug-resistant tuberculosis patients on the basis of the annual report database for 2007-2009 in Japan].

Kekkaku : [Tuberculosis]·2012

Same author

Computerized surveillance system of tuberculosis in Japan: its evolution, achievement and challenges.

Kekkaku : [Tuberculosis]·2012

Same author

[The use of nationwide tuberculosis surveillance system data to determine geographical differences in drug resistance--consideration of the representativeness of the drug resistance rate in Japan].

Kekkaku : [Tuberculosis]·2011

Same author

[Nontuberculous mycobacteriosis mortality in Japan].

Kekkaku : [Tuberculosis]·2011

Same author

[Trends in tuberculosis infection among foreigners in Japan according to work status].

Kekkaku : [Tuberculosis]·2010

Search research articles

Related Experiment Video

Updated: Jun 26, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

[Evaluation of the tuberculosis control program through tuberculosis surveillance].

Masako Ohmori¹

¹Research Institute of Tuberculosis, JATA, 3-1-24, Matsuyama, Kiyose-shi, Tokyo 204-8533, Japan. ohmori@jata.or.jp

Kekkaku : [Tuberculosis]

|January 29, 2009

Summary

Effective tuberculosis (TB) surveillance requires data collection, analysis, feedback, and action plans. Japan

Area of Science:

Public Health
Epidemiology
Health Informatics

Context:

Tuberculosis (TB) surveillance systems are crucial for monitoring and controlling infectious diseases.
Japan has a long history of developing and refining its national TB surveillance system since 1987.
The system has evolved to include automated treatment outcome assessment and optional modules for DOTS and contact tracing.

Purpose:

To evaluate the effectiveness of national and regional TB control programs in Japan.
To identify and address the inaccuracies in TB surveillance data collected at public health centers.
To propose an optimized approach for evaluating regional TB control programs and advocate for a national TB surveillance committee.

Summary:

The study highlights the evolution of Japan's TB surveillance system, emphasizing the integration of data collection, analysis, feedback, and action plans for effective program surveillance.

Related Experiment Videos

Last Updated: Jun 26, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Despite advancements, data accuracy remains a challenge, necessitating a focus on improving data quality within regional TB control programs.

The paper proposes a four-step evaluation approach (observe, set goals, announce strategy, annual evaluation) and recommends establishing a national TB surveillance committee to support declining TB specialists.

Impact:

Improved accuracy and quality of TB surveillance data leading to more effective TB control strategies.
Enhanced regional and national TB control program evaluations through a structured and systematic approach.
Establishment of a national TB surveillance committee to provide crucial support and guidance for TB control efforts in Japan.